These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2844089)

  • 1. Safety and tolerability of lisinopril in older hypertensive patients.
    Rush JE; Lyle PA
    Am J Med; 1988 Sep; 85(3B):55-9. PubMed ID: 2844089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with lisinopril. Observations on safety and tolerability.
    Cameron HA; Higgins TJ
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():177-86. PubMed ID: 2550641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension.
    Goldberg AI; Dunlay MC; Sweet CS
    Am J Cardiol; 1995 Apr; 75(12):793-5. PubMed ID: 7717281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of lisinopril in older patients with essential hypertension.
    Gomez HJ; Smith SG; Moncloa F
    Am J Med; 1988 Sep; 85(3B):35-7. PubMed ID: 2844085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety and tolerability of lisinopril in clinical trials.
    Rush JE; Merrill DD
    J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S99-107. PubMed ID: 2442561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of international safety data for lisinopril-hydrochlorothiazide combination treatment.
    Murray NH
    J Hum Hypertens; 1991 Dec; 5 Suppl 2():63-7; discussion 68. PubMed ID: 1665180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of angiotensin-converting enzyme inhibition: implications for tolerability.
    Murray NH
    Cardiology; 1991; 79 Suppl 1():22-9. PubMed ID: 1655262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of lisinopril versus atenolol for mild to moderate essential hypertension.
    Beevers DG; Blackwood RA; Garnham S; Watson M; Mehrzad AA; Admani K; Angell-James JE; Feely M; Kumar S; Husaini MH
    Am J Cardiol; 1991 Jan; 67(1):59-62. PubMed ID: 1846057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 52-week comparison of lisinopril, hydrochlorothiazide, and their combination in hypertension.
    Kochar MS; Bolek G; Kalbfleisch JH; Olzinski P
    J Clin Pharmacol; 1987; 27(5):373-7. PubMed ID: 2826549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lisinopril: dose-peak effect relationship in essential hypertension.
    Cirillo VJ; Gomez HJ; Salonen J; Salonen R; Rissanen V; Bolognese JA; Nyberg R; Kristianson K
    Br J Clin Pharmacol; 1988 May; 25(5):533-8. PubMed ID: 2841960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multicenter clinical study of the antihypertensive activity of lisinopril].
    Cinotti GA; Bossini A; Cagli V; Corea L; Di Veroli C; Morabito S; Pierucci A; Porcellati C; Savino K; Timio M
    Minerva Med; 1989 Jan; 80(1):53-63. PubMed ID: 2536907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antihypertensive effect and safety of lisinopril in patients with mild to moderate essential hypertension. A Belgian multicenter study.
    Thomson M; Droussin AM; De Lame PA
    Acta Cardiol; 1990; 45(4):297-309. PubMed ID: 2173313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lisinopril and captopril in the treatment of heart failure in older patients. Comparison of a long- and short-acting angiotensin-converting enzyme inhibitor.
    Giles TD; Fisher MB; Rush JE
    Am J Med; 1988 Sep; 85(3B):44-7. PubMed ID: 2844087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double blind comparative study of lisinopril and enalapril in patients with essential hypertension.
    Johnston GD; Banks DC; Davies S; Duffin D; Garnham JC; Nicholls DP; Raj MV; Mansy S; Sloan P; Strouthidis TM
    J Hum Hypertens; 1991 Oct; 5(5):405-10. PubMed ID: 1663163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lisinopril in the treatment of hypertension.
    Messerli FH; Kaesser UR
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():17-21. PubMed ID: 2550640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of lisinopril and nifedipine retard in essential hypertension: a double-blind, placebo-controlled trial.
    Richardson PJ; Meany TB; Johnston GD; Kondowe G; Grimmer SF; Breckenridge AM
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S96-8. PubMed ID: 2455154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma lipid profiles and antihypertensive agents: effects of lisinopril, enalapril, nitrendipine, hydralazine, and hydrochlorothiazide.
    Williams LL; Lopez LM; Thorman AD; Quay GP; Stein GH; Mehta JL
    Drug Intell Clin Pharm; 1988; 22(7-8):546-50. PubMed ID: 2843341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACE inhibitors in mild to moderate hypertension: comparison of lisinopril and captopril administered once daily. French Cooperative Study Group.
    Gosse P; Dallocchio M; Gourgon R
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():23-8. PubMed ID: 2550642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive and renal effects of lisinopril in older patients with hypertension.
    Laher MS; Donohoe JF; Kelly JG; Doyle GD
    Am J Med; 1988 Sep; 85(3B):38-43. PubMed ID: 2844086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of antihypertensive efficacy of lisinopril compared to metoprolol in moderate to severe hypertension.
    Zachariah PK; Bonnet G; Chrysant SG; DeBacker G; Goldstein R; Herrera J; Lindner A; Materson BJ; Maxwell MH; McMahon FG
    J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S53-8. PubMed ID: 2442553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.